Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation.

[1]  R. Wolf,et al.  Are there advantages in the use of specific pathogen‐free baboons in pig organ xenotransplantation models? , 2014, Xenotransplantation.

[2]  E. Cozzi,et al.  Immunological challenges and therapies in xenotransplantation. , 2014, Cold Spring Harbor perspectives in medicine.

[3]  M. Sykes,et al.  Xenotransplantation: immunological hurdles and progress toward tolerance , 2014, Immunological reviews.

[4]  R. F. Hoyt,et al.  One‐Year Heterotopic Cardiac Xenograft Survival in a Pig to Baboon Model , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  D. Cooper,et al.  New Concepts of Immune Modulation in Xenotransplantation , 2013, Transplantation.

[6]  J. Smolen,et al.  B-cell targeted therapeutics in clinical development , 2013, Arthritis Research & Therapy.

[7]  S. Allen,et al.  Postoperative care and complications after ventricular assist device implantation. , 2012, Best practice & research. Clinical anaesthesiology.

[8]  Ashutosh Kumar Singh,et al.  B‐Cell Depletion Extends the Survival of GTKO.hCD46Tg Pig Heart Xenografts in Baboons for up to 8 Months , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  H. Tazelaar,et al.  Comparison of Gal and Non-Gal-Mediated Cardiac Xenograft Rejection , 2011, Transplantation.

[10]  D. Cooper,et al.  Therapeutic issues in the treatment of vascularized xenotransplants using gal-knockout donors in nonhuman primates , 2011, Current opinion in organ transplantation.

[11]  P. Linsley,et al.  Pillars article: long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 1996. 381: 434-438. 1996. , 2011, Journal of immunology.

[12]  R. F. Hoyt,et al.  Surgical and nonsurgical complications of a pig to baboon heterotopic heart transplantation model. , 2010, Transplantation proceedings.

[13]  D. Cooper,et al.  Recipient Tissue Factor Expression Is Associated With Consumptive Coagulopathy in Pig‐to‐Primate Kidney Xenotransplantation , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Marvin L. Thomas,et al.  Left ventricular pressure measurement by telemetry is an effective means to evaluate transplanted heart function in experimental heterotopic cardiac xenotransplantation. , 2010, Transplantation proceedings.

[15]  D. Cooper,et al.  Overcoming the barriers to xenotransplantation: prospects for the future , 2010, Expert review of clinical immunology.

[16]  P. O’Connell.  Thrombotic microangiopathy: the next big hurdle for xenotransplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  Keiji Oi,et al.  Cardiac xenotransplantation : Recent preclinical progress with 3-month median survival , 2005 .

[18]  R. Pierson,et al.  Co‐stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig‐to‐baboon cardiac xenograft , 2005, Xenotransplantation.

[19]  R. Colvin,et al.  Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates1 , 2004, Transplantation.

[20]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[21]  S. Robson,et al.  Anti-CD154 monoclonal antibody and thromboembolism. , 2001, Transplantation.

[22]  P. Linsley,et al.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.

[23]  Marvin L. Thomas,et al.  Role of anti‐CD40 antibody‐mediated costimulation blockade on non‐Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig‐to‐baboon model , 2014, Xenotransplantation.

[24]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[25]  T. Starzl,et al.  Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.